The paraventricular nucleus of the hypothalamus (PVH) contains a heterogeneous cluster of Sim1-expressing cell types that comprise a major autonomic output nucleus and play critical roles in the control of food intake and energy homeostasis. 
Introduction
The paraventricular nucleus of the hypothalamus (PVH) is the major autonomic output area of the hypothalamus and is critical for energy homeostasis. Loss of one copy of single-minded 1 (Sim1), a key transcription factor regulating PVH development, disrupts PVH maturation and function, resulting in hyperphagic obesity with associated glucose dysregulation in mammals (Michaud et al., 1998; Holder et al., 2000) . Similar metabolic derangements also result from electrolytic destruction of the PVH (Gold, 1973; Sims and Lorden, 1986) . In addition, the PVH serves as an important regulatory center for peptidergic signals and physiologic parameters known to modulate food intake, including leptin, melanocortins, and dehydration (Cowley et al., 1999; McKinley and Johnson, 2004) . Indeed, the melanocortin pathway is essential for energy balance in mammals and is directly linked to PVH function. Leptin-responsive neurons in the arcuate nucleus project to the PVH, a site of dense melanocortin receptor expression, and release melanocortin agonists and antagonists/inverse agonists to modulate PVH function (Cowley et al., 1999; Kishi et al., 2003) . Consistent with its role in feeding, the PVH sends dense projections to hindbrain regions such as the nucleus of the solitary tract (NTS) and parabrachial nucleus (PBN) to modulate feeding behaviors (Sawchenko and Swanson, 1982; Fulwiler and Saper, 1985; Blevins et al., 2004) . Although PVH functions are understood in broad terms, the specific cell types within this heterogeneous structure that regulate feeding are not fully defined.
In addition to modulating feeding, a variety of data suggest that PVH neurons control energy expenditure. For example, infusion of the melanocortin receptor agonist MTII into the PVH increases energy expenditure (Cowley et al., 1999) , while ablation of Sim1 neurons throughout the CNS decreases the metabolic rate (Xi et al., 2012) . Furthermore, polysynaptic retrograde tracing links thermogenic brown adipose tissue (BAT) to the PVH through the sympathetic nervous system via cholinergic [choline acetyltransferase (ChAT)] preganglionic neurons in the intermediolateral column of the thoracic spinal cord (ChAT IML ; Bamshad et al., 1999) . Similar to the PVH cells that control feeding, the neurochemical identity of the PVH neurons regulating energy expenditure via the sympathetic nervous system (SNS) has yet to be established.
Given the role of the PVH in energy balance, we sought to identify subsets of Sim1-expressing PVH (Sim1 PVH ) neurons that contribute to energy homeostasis and reveal their roles in food intake or energy expenditure. We discovered that PVH containing nitric oxide synthase-1 (Nos1)-expressing (Nos1 PVH ) neurons are a subset of Sim1 PVH neurons and send dense projections to hindbrain regions important for feeding control and to the upper thoracic spinal cord that regulates sympathetic output. Moreover, Nos1 PVH neuron activation regulates both feeding and energy expenditure, indicating the critical importance of Nos1 PVH neurons in PVHregulated energy balance. In addition, oxytocin-expressing PVH neurons (OXT PVH ) neurons represent a subset of Nos1 PVH neurons that project to and modulate ChAT IML neurons, yet make only a small contribution to energy balance. These studies demonstrate discrete roles for Nos1 PVH and OXT PVH neurons in energy balance, and position these neurons anatomically and functionally in the neural circuitry of energy balance.
Materials and Methods
Experimental animals. Oxytocin-ires-Cre (OXT-iCre), Nos1-ires-Cre (Nos1-iCre), and Sim1-Cre mice were generated as described previously (Balthasar et al., 2005; Leshan et al., 2012; Wu et al., 2012) . Adult male mice (8 -12 weeks old) were used for all studies. OXT-iCre, Nos1-iCre, or Sim1-iCre mice were bred to a Cre-dependent GFP reporter line (Bergner et al., 2014) to fluorescently label Cre-expressing PVH subpopulations. All animals were bred and housed within our colony according to guidelines approved by the University of Michigan Committee on the Care and Use of Animals. Unless otherwise noted, mice were provided ad libitum access to food and water.
Stereotaxic injections. OXT-iCre, Nos1-iCre, Sim1-Cre, and nontransgenic [wild-type (WT)] mice were given presurgical analgesia and anesthetized with isoflurane. Mice were placed in a digital stereotaxic frame (Model 1900, Kopf Instruments), and the skull was exposed. Intracranial injection coordinates were determined from bregma using the stereotaxic atlas of Paxinos and Franklin (2001) . Viral injections were performed using a pressurized picospritzer system coupled to a pulled glass micropipette [coordinates from bregma: anteroposterior, Ϫ0.500; mediolateral, Ϯ0.220; dorsoventral (D/V), Ϫ4.800]. For tract-tracing experiments, 50 -150 nl of the adenoviral synatophysin-mCherry terminal tracer (Ad-iN/syn-mCherry; Opland et al., 2013) was unilaterally injected into Sim1-Cre, Nos1-iCre, or OXT-iCre mice. Additionally, stereotaxic injection of Red Retrobeads (RRs; Lumafluor) was performed in the NTS of Sim1-Cre and Nos1-iCre mice with a Cre-dependent GFP reporter (lox-GFP). Control mice also received unilateral injection of RRs to determine PVH-NTS connections using OXT peptide staining. For NTS injections, mice were anesthetized and placed in the digital stereotax. The fourth ventricle was identified and used as a geographic landmark to determine the site of injection. A glass micropipette was lowered into the site (D/V, Ϫ0.630) and ϳ25 nl of RRs was injected. For functional analysis of PVH neurons, bilateral PVH injections of AAVhM3Dq-mCherry (AAV-hM3Dq, purchased from the University of North Carolina Vector Core, Chapel Hill, NC) were performed in Sim1-Cre (50 nl/side), Nos1-iCre (50 nl/side), and OXT-iCre (75 nl/side) mice. To control for viral transduction, nontransgenic (WT) mice also received bilateral injections of AAV-hM3Dq (75 nl/side). Mice injected with the Ad-iN/syn-mCherry tracer were individually housed for 5 d following injection to allow for viral transduction and protein transport before perfusion, whereas mice injected with RRs were perfused after 7 d following injections. Mice injected with AAV-hM3Dq were allowed to recover for 7 d following surgery before further experiments were performed.
Food intake measurements. Following recovery, Nos1-iCre, OXT-iCre, Sim1-Cre, and WT mice with bilateral PVH AAV-hM3Dq injections were given PBS (intraperitoneally) for 3 consecutive days to allow for injection acclimatization. Before assessment, mice were fasted during the light cycle (9:00 A.M. to 6:00 P.M.) and had ad libitum access to water. Mice were then injected with vehicle [10% (2-hydroxypropyl)-␤-cyclodextrin; catalog #C0926, Sigma) at the onset of feeding (6:00 P.M.) and food intake was measured at 2, 4, and 16 h (overnight) postinjection. The following day, mice were injected with clozapine-N-oxide (CNO) at the onset of feeding (0.3 mg/kg in 10% ␤-cyclodextrin), and food intake was measured at 2, 4, and 16 h following injection.
Energy expenditure measurements. Energy expenditure was measured using the Comprehensive Laboratory Monitoring System (CLAMS, Columbus Instruments) in the University of Michigan Small Animal Phenotyping Core to obtain multiparameter analysis, including open circuit calorimetry and activity via optical beam breaks. AAV-hM3Dq-injected mice were acclimatized to the sealed chambers for 2 d with free access to food and water. The experimentation room had 12 h dark/light cycles (6:00 P.M. to 6:00 A.M.), and the temperature was maintained at 20 -23°C. On experimental days (Day 3 and Day 4), food was removed at 9:00 A.M., and vehicle (Day 3) or CNO (Day 4, 0.3 mg/kg) was injected at 11:00 A.M. Food was then replaced at the onset of the dark cycle (6:00 P.M.). Although measurements [oxygen consumption (VO 2 ), carbon dioxide production, and spontaneous motor activity] were performed throughout the duration of the experiment, the data shown are the averaged VO 2 or activity over the 4 h following injection of vehicle or CNO.
Intrascapular temperature measurements. The University of Michigan Small Animal Phenotyping Core placed temperature transponders (IPTT-300 model with corresponding DAS-7007R reader, Bio Medic Data Systems) in the intrascapular subcutaneous tissue directly above brown adipose tissue under isoflurane anesthesia. Mice were allowed to recover for 14 d before testing. On the day of testing, food was removed from the cages at 9:00 A.M. Two hours later, mice with PVH-directed AAV-hM3Dq injections were injected with vehicle or CNO, and temperatures were recorded before injection and at 15, 30, 60, and 120 min following injection.
Perfusion and immunohistochemistry. For tract-tracing experiments, mice were perfused 5 d (Ad-iN/syn-mCherry) or 7 d (RRs) after intracranial injection. At the end of the neuronal activation studies, mice with bilateral AAV-hM3Dq injections were treated with either vehicle or CNO and perfused 90 min later, as described previously (Münzberg et al., 2007) . Briefly, mice were deeply anesthetized with an overdose of pentobarbital (150 mg/kg, i.p.) and transcardially perfused with sterile PBS followed by 10% neutral buffered formalin or 4% paraformaldehyde (for perfusions with spinal cord removal). Brains and spinal cords were removed, post-fixed, and dehydrated in 30% sucrose before sectioning into 30 m slices on a freezing microtome (Leica). Coronal brain sections were collected in four representative sections, whereas longitudinal thoracic spinal cord sections were collected in three representative sections and stored at Ϫ20°C. For Fos immunohistochemistry (IHC), freefloating brain and spinal cord sections were pretreated with 30% H 2 O 2 to remove endogenous peroxidase activity, and then were blocked with normal goat or donkey serum and incubated in primary antibody overnight (rabbit anti-cFos 1:10,000; PC38, Calbiochem). Detection of primary antibody was performed by the avidin-biotin/diaminobenzidine (DAB) method (Biotin-SP-conjugated Donkey Anti-Rabbit, 1:200, Jackson ImmunoResearch; ABC kit, Vector Laboratories; DAB reagents, Sigma). hM3Dq and ChAT were detected using primary antibodies against red fluorescent protein (RFP; rat 1:2000, Allele Biotechnology) and ChAT (spinal cords only; goat, 1:500; AB144P, Millipore), respectively, followed by secondary immunofluorescence detection with donkey anti-rat-Alexa Fluor 568 or donkey anti-goat-Alexa Fluor 488 (1:200, Invitrogen). For PVH colocalization experiments, IHC immunostaining was performed using primary antibodies for GFP (rabbit, 1:20,000, Invitrogen A6455), nNOS1 (sheep, 1:2500; Herbison et al., 1996 ; provided by Dr. Vincent Prevot, Inserm, Lille, France), or oxytocin (rabbit, 1:2500; catalog #T-4084, Peninsula Laboratories). For tract-tracing experiments, immunostaining was performed using primary antibodies for RFP, GFP, or oxytocin.
Immunoblotting of BAT UCP1 protein. Sim1-Cre, OXT-iCre, and WT mice with bilateral PVH AAV-hM3Dq injections were given either vehicle or CNO and 90 min later mice were anesthetized with pentobarbital, and BAT was removed, frozen on dry ice, and stored at Ϫ80°C. Tissue was homogenized in protein lysis buffer (10% SDS, 1 M Tris, pH 6.8, 12.7 mM EDTA) with metal beads in a Bullet blender for 30 min. Samples were clarified by centrifugation, and protein concentration was quantified by BCA assay (catalog #23225, Thermo Scientific). Lysates were diluted to equal protein concentration in lysis buffer plus 1ϫ NuPage SDS buffer (Invitrogen) with 2.5% 2-mercaptoethanol. Samples were boiled for 5 min and loaded on an SDS gradient polyacrylamide gel (Invitrogen), and separated by electrophoresis. Proteins were transferred to Immobilon PVDF membranes (Millipore), and Ponceau staining of membranes was used to confirm equal protein loading between lanes. Membranes were blocked in 5% milk for 1 h at room temperature and then incubated with primary antibodies (goat anti-UCP1, 1:2000, catalog #SC-6528, Santa Cruz Biotechnology; rat anti-␣-tubulin, 1:1000, catalog #MA1-80017, Thermo Scientific) and appropriate HRP-conjugated secondary antibodies (1:5000 dilution in 5% milk, IgG peroxidase; GE Healthcare) in 5% BSA. Super Signal enhanced chemiluminescence (Pierce) was used for visualization by autoradiography, and bands were quantified by densitometry.
Statistical analysis. Paired t tests, unpaired t tests, or repeatedmeasures two-way ANOVAs were calculated using GraphPad Prism. Significance was determined at p Ͻ 0.05.
Results

nNos1 (Nos1) expression defines a PVH subpopulation
Nos1 in situ hybridization (Allen Brain Atlas) and Nos1-iCre, lox-GFP reporter mice demonstrate the existence of NOS1-containing neurons in the PVH. To determine whether NOS1 peptide marks a neuronal subset of the entire PVH, we stained brains from Sim1-Cre, lox-GFP reporter mice for GFP and NOS1 immunoreactivity (IR) and found that all Nos1 PVH neurons express Sim1, but not all Sim1 PVH neurons express NOS1 ( Fig.  1 A, B) . PVH cell counts in Sim1-Cre, lox-GFP brain slices immunostained for Nos1 peptide (n ϭ 5) revealed that Nos1 PVH neurons account for ϳ21% of the Sim1 PVH field. To identify some potential Nos1
PVH subtypes, we also investigated the overlap between Nos1
PVH and OXT PVH neurons. Using Nos1-iCre, lox-GFP sections, we found that almost all OXT PVH neurons (ϳ90%, n ϭ 3) contain GFP, whereas only 16% (n ϭ 3) of Nos1-iCre PVH neurons contain OXT peptide. This confirms that OXT PVH neurons are a subset of Nos1 PVH neurons (Fig. 1C,D) . This establishes that Nos1 PVH neurons represent a discrete subset of Sim1 PVH neurons and that most OXT PVH neurons lie within the Nos1 PVH field (Fig. 1E ). Given the importance of Sim1 PVH neurons in energy balance regulation and the limited information regarding the roles of specific PVH subtypes in this regulation, we investigated the potential contributions of Nos1 PVH and OXT PVH neurons to the control of energy balance parameters.
Nos1
PVH neurons send dense projections to hindbrain regions important for satiety As hindbrain regions [e.g., NTS/dorsal motor nucleus of the vagus (DMV), PBN, and specifically PVH ¡ NTS neuronal projections] have been implicated in feeding regulation, we charac- terized efferent projections from defined PVH subpopulations to the NTS/DMV and the PBN. We used Sim1 PVH neurons as a reference group to establish projection targets for comparison with Nos1 PVH and OXT PVH subsets. Sim1-Cre mice were unilaterally injected with a Cre-dependent Ad-iN/syn-mCherry tracer ( Fig. 2A) , which traffics predominantly to synaptic terminals and preferentially identifies projection terminals as opposed to axons of passage. We observed dense Sim1 PVH neuron-derived mCherry-IR (Fig. 2B ) in hindbrain regions important for satiety, including the medial PBN (mPBN) and lateral PBN (lPBN; Fig. 2C ) and the NTS (Fig. 2D ). Similar mCherry-IR was observed in these hindbrain regions from Nos1 PVH neurons injected with Ad-iN/synmCherry ( Fig. 2F-H ). In contrast, we detected very little OXT PVH -derived syn-mCherry in the PBN (Fig. 2K) or NTS (Fig. 2L) . Unilateral PVH injections of Ad-iN/syn-mCherry in OXT-iCre mice demonstrated syn-mCherry expression (Fig. 2J, red) only in OXT-PVH neurons (Fig. 2J, green) , confirming the fidelity of the Credependent Ad-iN/syn-mCherry virus. As expected, Sim1 PVH , Nos1 PVH , and OXT PVH neurons also sent dense projections to the median eminence, reflecting the parvocellular PVH subpopulation projections that influence pituitary function and the magnocellular projections that release their contents directly from the posterior pituitary into the systemic circulation (Fig. 2E,I,M) .
To better characterize the PVH neurons that project to the NTS/DMV and potentially affect feeding behaviors, we injected fluorescent latex microspheres (RRs, Lumafluor) unilaterally into the NTS of Sim1-Cre, lox-GFP, Nos1-iCre, lox-GFP, and wild-type mice (Fig. 3 A, E,J, respectively). RRs are preferentially taken up by presynaptic terminals at the site of injection and undergo retrograde transportation back to the cell body, thus allowing neuron identification by autofluorescence. As might be expected, all RR-labeled PVH neurons from Sim1-Cre, loxGFP animals coexpress GFP, suggesting that all PVH ¡ NTS projections originate from Sim1 PVH neurons (Fig. 3B-D) . Retrograde labeling from the NTS/DMV in Nos1-iCre, lox-GFP mice also demonstrates extensive (but not complete) overlap between NTS-projecting RR-labeled neurons and Nos1 PVH neurons ( Fig.  3F-H ) . Since previous reports suggest the presence of OXT PVH projections to the NTS/DMV and essentially all OXT PVH neurons are within the Nos1-iCre PVH field, we costained Nos1-iCre, lox-GFP mice with NTS RR injections for OXT peptide (Fig. 3I I -I IV ). As expected, OXT-IR is seen within Nos1 PVH neurons (Fig. 3I IV , green, open arrowheads); however, NTS-injected RRs predominantly labeled Nos1 PVH neurons that do not contain OXT (white arrowheads). In agreement with these findings, very few OXT PVH cell bodies were labeled with NTS-injected RRs (Fig. 3J-M ) in separate control mice, even though OXT peptide (green) was detectable in the NTS/DMV at the site of the RR injection (Fig.  3J ). This suggests that much of the OXT-IR in the NTS identifies fibers of passage, as opposed to synaptic terminals. Nevertheless, it is the non-OXT Nos1 PVH neurons that comprise the bulk of the NTS-projecting Nos1 PVH neurons.
PVH and OXT PVH neurons project to the spinal cord Since sympathetic outflow promotes energy expenditure and the PVH is implicated in energy expenditure regulation, we also investigated whether Nos1 PVH and OXT PVH neurons project to hindbrain and spinal cord regions important for SNS control (Cowley et al., 1999; Xi et al., 2012) . The raphe pallidus (RPa) is an important hindbrain region controlling BAT function and energy expenditure (Bamshad et al., 1999; Morrison, 1999; Cano et al., 2003) . We found few syn-mCherry terminals originating from Sim1 PVH (Fig. 4A ), Nos1 PVH (Fig. 4B ), or OXT PVH (Fig. 4C ) neurons in the RPa. To determine whether Sim1 PVH , Nos1 PVH , and OXT PVH neurons project to the preganglionic, sympathetic output neurons of the thoracic spinal cord, we also examined longitudinal spinal cord sections from Sim1-Cre, Nos1-iCre, or OXT-iCre mice following unilateral PVH Ad-iN/syn-mCherry injections. We identified robust syn-mCherry tracer in thoracic spinal cord regions originating from Sim1 PVH (Fig. 4D ), Nos1 PVH (Fig. 4E) , and OXT PVH neurons (Fig. 4F ) . Syn-mCherry-IR is localized in close proximity to neurons expressing ChAT in the ChAT IML , suggesting potential Sim1 PVH , Nos1 PVH , and OXT PVH neuronal connections with and regulation of IML preganglionic sympathetic neurons (Fig. 4DЈ ,EЈ,FЈ).
Temporal control of PVH neuronal subpopulations
Having established the anterograde projection targets for Sim1 PVH , Nos1 PVH , and OXT PVH neurons, we tested the physiologic effects of acute activation of these PVH neurons on feeding and energy expenditure. To selectively activate these PVH subsets, we used Designer Receptors Exclusively Activated by Designer Drugs (DREADDs) technology (Alexander et al., 2009) . The hM3Dq DREADD is a modified human muscarinic receptor designed to couple with stimulatory Gq-proteins. Binding of an otherwise inert, synthetic ligand, CNO, activates neurons expressing hM3Dq. This system has been engineered to be Cre recombinase-dependent to achieve cell-specific control (Fig. 5A) . Thus, site-specific injection of a Cre-dependent adeno-associated virus (AAV)-hM3Dq allows for remote and temporal activation only of neurons that express Cre recombinase. As for our tracing studies, we used Sim1-Cre mice to target the majority of PVH neurons and to establish an upper threshold of PVH "output capacity" upon DREADD activation followed by Nos1 PVH and OXT PVH subset activation. As a control for DREADD injection, bilateral PVH injections of AAV-hM3Dq into WT mice were also performed.
Although AAV-hM3Dq was primarily limited to the PVH of Sim1-Cre-injected mice, there was a small amount of AAVhM3Dq expression in Sim1-Cre ϩ areas in the anterior hypothalamus (Fig. 5B) . Similarly, while injections in Nos1-iCre mice were targeted for the PVH, some Nos1-iCre ϩ neurons in the thalamus also expressed hM3Dq (Fig. 5C) . Importantly, any injected Nos1-iCre animals that expressed hM3Dq in peri-PVH areas implicated in feeding (i.e., dorsomedial hypothalamus) were excluded from the analysis. PVH injections of AAV-hM3Dq were restricted to OXT PVH neurons, as Cre expression in OXT-iCre mice is limited to the PVH and supraoptic nucleus (SON; Fig. 5D ). Using nuclear Fos staining as an indicator of neuronal activation, vehicle injection caused little PVH activation in Sim1-Cre (Fig.   5E ), Nos1-iCre (Fig. 5F ), or OXT-iCre (Fig. 5G) mice with bilateral PVH AAV-hM3Dq injections. In contrast, hM3Dq-injected mice treated with CNO before perfusion demonstrated a marked increase in nuclear Fos staining in transduced PVH neurons (Fig.  5H-J ) . Specifically, CNO stimulated PVH nuclear Fos expression in Sim1-CreϩAAV-hM3Dq mice [176.5 Ϯ 6.5 vs 51.0 Ϯ 6.0 (vehicle); n ϭ 2 each; unpaired t test, t (2) ϭ 14.2, p ϭ 0.005), Nos1-iCreϩAAV-hM3Dq mice (200.7 Ϯ 39.0 vs 36.0 Ϯ 5.0 (vehicle); vehicle, n ϭ 2; CNO, n ϭ 3; unpaired t test, t (3) ϭ 3.3, p ϭ 0.047] and OXT-iCreϩAAV-hM3Dq mice [130 Ϯ 14 vs 63.0 Ϯ 5.1 (vehicle); n ϭ 4 each; unpaired t test, t (6) ϭ 4.4, p ϭ 0.005]. This demonstrates that cell-specific DREADD expression allows for temporal control of PVH neuron activity. Nuclear Fos was also apparent in non-Cre-expressing cells, suggesting that PVH subtypes can activate neighboring PVH cells via local connections (Fig. 5J, inset ; Boudaba et al., 1996; Ziegler and Herman, 2000). We detected no hM3Dq expression or CNO-dependent activation in the PVH of wild-type control mice (data not shown). 
Direct activation of PVH neurons alters food intake
Based on our anterograde tracing of PVH subsets, we hypothesized that activation of Sim1 PVH and Nos1 PVH neurons would alter feeding (via projections to hindbrain regions). To test this hypothesis, we injected AAV-hM3Dq bilaterally into the PVH of Sim1-Cre, Nos1-iCre, and OXT-iCre mice, and treated these animals with CNO (0.3 mg/kg) at the onset of dark cycle feeding. Body weights (ϮSEM) of the animals used in these studies are as follows: Sim1-Cre, 22.6 Ϯ 1.6 g (n ϭ 4); Nos1-iCre, 25.6 Ϯ 0.7 g (n ϭ 8); OXT-iCre, 22.8 Ϯ 0.8 g (n ϭ 10); WT, 24.1 Ϯ 0.8 g (n ϭ 4). Wild-type controls with bilateral PVH AAV-hM3Dq injections showed no change in feeding behavior in response to CNO compared with vehicle injections, demonstrating that neither viral transduction nor CNO alone altered food intake (Fig. 6A, first  panel) . Activation of Sim1 PVH neurons robustly suppressed feeding compared with vehicle control (Fig. 6A , second panel; paired t test, t (3) ϭ 5.0, p ϭ 0.015). As hypothesized, Nos1-iCre mice with bilateral AAV-hM3Dq injections also ate significantly less following CNO activation of Nos1 PVH neurons compared with vehicle ( Fig. 6A , third panel; paired t test, t (7) ϭ 7.9, p Ͻ 0.0001). Interestingly, the 2 h suppression of food intake following activation of Sim1 PVH and Nos1 PVH neurons is comparable (t (10) ϭ 1.0, p ϭ 0.35, unpaired t test), suggesting that the anorexia associated with Sim1 PVH activation is mediated largely via Nos1 PVH neurons. The anorectic effect of Nos1 PVH activation persists through 4 h of refeeding (paired t test, t (7) ϭ 11.2, p Ͻ 0.0001; there is a similar trend for Sim1 PVH neuron activation; Fig. 6B ), although total overnight food intake (16 h) approximates that of controls (Fig.  6C) . In contrast to Sim1 PVH and Nos1 PVH neurons, activation of OXT PVH neurons had little effect on 2 or 4 h food intake ( Fig.  6 A, B, fourth panel) . Thus, Nos1
PVH neuron activation suppresses feeding to a similar extent as Sim1 PVH neurons, suggesting a major role for Nos1 PVH neurons in the control of food intake. Furthermore, since activation of the OXT-containing subset of Nos1 PVH neurons fails to blunt feeding, the activation of non-OXT Nos1 PVH neurons must be required for this effect.
Activation of PVH neurons increases Fos expression in sympathetic output neurons and promotes energy expenditure
The role of the PVH in modulating energy expenditure has received less attention than its contribution to feeding regulation. Given the robust spinal cord projections from Sim1 PVH , Nos1 PVH , and OXT PVH neurons, we determined the effect of DREADD-mediated activation of these PVH neural subsets on nuclear Fos expression in preganglionic, sympathetic output neurons and overall oxygen consumption. First, we treated Sim1-CreϩAAV-hM3Dq, Nos1-iCreϩAAV-hM3Dq, or OXTiCreϩAAV-hM3Dq mice with vehicle ( Fig. 7 A, C,E) or CNO (Fig. 7 B, D,F PVH or Nos1 PVH neurons decreases 2 h food intake whereas activation of OXT PVH neurons had no effect on food intake. B, Activation of Nos1 PVH neurons also significantly decrease 4 h food intake, and Sim1 PVH neuronal activation shows a similar trend, though this is not significant. C, Cumulative overnight food intake (16 h) is not altered by activation of PVH neuronal subsets. Average values Ϯ SEM are shown. *p Ͻ 0.05, ***p Ͻ 0.01, ****p Ͻ 0.0001 compared with vehicle values (WT, n ϭ 5; Sim1-Cre, n ϭ 4; Nos1-iCre, n ϭ 8; OXT-iCre, n ϭ 10). Significance was determined using two-tailed paired t test.
nuclear Fos expression in ChAT IML neurons with 42.6 Ϯ 7.2% (CNO-treated) versus 16.1 Ϯ 5.4% (vehicle-treated) ChAT IML neurons counted (n ϭ 2 each; unpaired t test, t (2) ϭ 2.9, p ϭ 0.099). These data thereby suggest a potential neuroanatomical pathway for the regulation of sympathetic output and energy expenditure.
To determine the ability of each PVH subset to modulate energy expenditure, we used metabolic cages to measure VO 2 and locomotor activity in animals expressing hM3Dq in Sim1 PVH , Nos1
PVH , and OXT PVH neurons. Activation of Sim1 PVH neurons and Nos1
PVH neurons increased the average oxygen consumption in the absence of food [ Fig. 8 A, B , second and third panels; Sim1: paired t test; average 4 h VO 2 , t (3) ϭ 8.8, p ϭ 0.003; average 4 h VO 2 lean body mass (LBM), t (3) ϭ 11.0, p ϭ 0.002; Nos1: average 4 h VO 2 , t (3) ϭ 3.2, p ϭ 0.05; average 4 h VO 2 LBM, t (3) ϭ 3.6 p ϭ 0.038]. Acute activation of OXT PVH neurons also significantly increased oxygen consumption (Fig. 8 A, B , fourth panel; average 4 h VO 2 , t (9) ϭ 2.4, p ϭ 0.042; average 4 h VO 2 LBM, t (9) ϭ 2.3, p ϭ 0.05), albeit not to the extent seen with activation of Nos1 PVH neurons (unpaired t test of average change in 4 h VO 2, t (13) ϭ 2.5, p ϭ 0.029). Baseline oxygen consumption was elevated in the initial cohort of OXT-iCreϩAAV-hM3Dq mice compared with other groups (one-way ANOVA of the average change in 4 h VO 2 , F (3,19) ϭ 7.3, p ϭ 0.002). To exclude the possibility that this elevated baseline O 2 consumption was a property of the OXT-iCre transgenic line, as opposed to a cohort effect, oxygen consumption experiments were repeated in a second cohort of mice naive to CNO (Fig. 8C,D) . Indeed, OXT-iCreϩAAV-hM3Dq mice treated with vehicle had the same baseline oxygen consumption as WT and OXT-iCre mice without AAV-hM3Dq (one-way ANOVA of average change in 4 h VO 2 , F (2,9) ϭ 1.0, p ϭ 0.4), indicating that OXT-iCre mice are not metabolically compromised.
Interestingly, activation of any of the PVH subpopulations increased average total activity, although not equally ( Fig. 8E; paired t test; Sim1ϩ3Dq, t (3) ϭ 4.7, p ϭ 0.019; Nos1ϩ3Dq, t (3) ϭ 26.8, p ϭ 0.0001; OXTϩ3Dq, t (9) ϭ 4.3, p ϭ 0.002). As expected, WTϩAAV-hM3Dq mice showed no change in oxygen consumption or activity in response to CNO (Fig. 8A-E) . Body weights (ϮSEM) of the animals used in these studies are as follows: Sim1-Cre, 30.5 Ϯ 2.1 g (n ϭ 4); Nos1-iCre, 29.4 Ϯ 0.9 g (n ϭ 4); OXT-iCreϩ3Dq cohort 1, 23.9 Ϯ 0.6 g (n ϭ 10); WT cohort 1, 26.3 Ϯ 1.3 g (n ϭ 4); OXT-iCreϩ3Dq cohort 2, 28.9 Ϯ 1.3 g (n ϭ 4); OXT-iCre (no 3Dq), 28.1 Ϯ 1.8 g (n ϭ 4); and WT cohort 2, 30.4 Ϯ 1.6 g (n ϭ 4). Therefore, Nos1
PVH or OXT PVH neuron Figure 8 . Acute activation of Nos1 PVH neurons increases energy expenditure. WTϩAAV-hM3Dq, Sim1-CreϩAAV-hM3Dq, and Nos1-iCre or OXT-iCreϩAAV-hM3Dq mice were injected with vehicle (white bars) or CNO (black bars). A, B, E, Activation of Sim1 PVH , Nos1 PVH or OXT PVH neurons increases average oxygen consumption (A, B) and total activity (E) over 4 h following injection. C, D, A second cohort of CNO-naive mice also shows a trend toward increased 4 h average VO 2 in response to activation of OXT PVH neurons, while baseline VO 2 is unchanged compared with WTϩ3Dq or OXT-iCre mice without 3Dq injections (WT, n ϭ 5; Sim1-Cre, n ϭ 4; Nos1-iCre, n ϭ 4; OXT-iCre cohort 1, n ϭ 10; WT cohort 2, n ϭ 4; OXT-iCreϩ3Dq cohort 2, n ϭ 4; OXT-iCre, n ϭ 4). F, To determine potential activity-independent changes in VO 2 , VO 2 was determined in Sim1-Creϩ3Dq and Nos1-iCreϩ3Dq mice before and after CNO treatment, at time points when locomotor activity was approximately matched at activity levels below a threshold value of 300 counts/h (bars indicate average values Ϯ SEM, line segments indicate individual mice; Sim1, n ϭ 4; Nos1, n ϭ 4). Average values Ϯ SEM are shown. *p Ͻ 0.05, **p Ͻ 0.01, ***p Ͻ 0.001 compared with vehicle values. Significance was determined using two-tailed paired t test within groups or unpaired t test between groups.
activation promotes locomotor activity and overall energy expenditure, although to a lesser extent than that seen with pan-PVH activation. Unlike the feeding effects observed with Nos1 PVH activation, Nos1 PVH -driven increases in VO 2 and activity were significantly smaller than those seen with Sim1 PVH activation (unpaired t test of average 4 h VO 2 , F (3,3) ϭ 1.062, p ϭ 0.009; unpaired t test of average 4 h activity, F (3,3) ϭ 274.3, p ϭ 0.023), suggesting that both Nos1 PVH and non-Nos1 PVH subsets of Sim1 neurons contribute to the control of energy expenditure. As increased locomotor activity may contribute to overall energy expenditure and VO 2 , we analyzed VO 2 in Sim1-CreϩAAV-hM3Dq and Nos1-iCreϩAAV-hM3Dq mice at time points when locomotor activity was approximately matched before and after CNO treatment (Fig. 8F ). While this analysis revealed a trend toward increased VO 2 for both Sim1-CreϩAAV-hM3Dq and Nos1-iCreϩAAV-hM3Dq animals when matched for activity (Sim1-Cre, paired t test, t (3) ϭ 2.4, p ϭ 0.093; Nos1-iCre, paired t test, t (3) ϭ 2.9, p ϭ 0.064), the magnitude of the effect was small relative to the overall increase in VO 2 . This suggests that increased locomotor activity contributes significantly to the increased oxygen consumption observed with PVH stimulation, but that changes independent of locomotor activity may also play a role.
Acute Sim1
PVH activation increases intrascapular BAT temperature Since the activation of PVH neurons tends to increase energy expenditure in mice matched for locomotor activity, and Sim1 PVH , Nos1 PVH , and OXT PVH neurons send dense projections to preganglionic sympathetic ChAT neurons in the thoracic spinal cord, we hypothesized that activation of these PVH subpopulations might promote thermogenesis in addition to potentially playing a role in locomotor activation. To test this, temperature transponders were placed in the subcutaneous tissue directly above intrascapular BAT in Sim1-CreϩAAVϩhM3Dq, OXT-iCreϩAAVϩhM3Dq, and WTϩAAVϩhM3Dq mice and intrascapular temperatures (T IS s) were measured before and after PVH neuron activation. Body weights (ϮSEM) of the animals used in these studies are as follows: Sim1-Cre, 27.4 Ϯ 1.6 g (n ϭ 3); OXT-iCre, 28.5 Ϯ 0.8 g (n ϭ 4); and WT, 31.5 Ϯ 1.2 g (n ϭ 5).
Activation of Sim1
PVH neurons increased T IS s when compared with baseline T IS s before injection of vehicle or CNO (Fig. 9 A, B ; repeated-measures two-way ANOVA of change in baseline T IS s, Since acute PVH activation increased T IS , we determined whether this was mediated by increased BAT uncoupling protein 1 (UCP1), the primary facilitator of BAT thermogenesis (Matthias et al., 2000) . We examined UCP1 protein levels in BAT from Sim1-CreϩAAV-hM3Dq, OXT-iCreϩAAV-hM3Dq, or WTϩAAV-hM3Dq mice treated with either vehicle or CNO. UCP1 protein levels did not change in response to Sim1 PVH or OXT PVH neuronal activation when normalized to the loading control (Fig. 10) . Therefore, increases in T IS following PVH activation may be due to mechanisms that increase UCP1 activity rather than protein levels (Divakaruni et al., 2012; Richard et al., 2012) .
Discussion
The importance of the PVH in feeding regulation, energy balance, and endocrine and autonomic function is well established (Sawchenko and Swanson, 1982; Cowley et al., 1999; Balthasar et al., 2005) . However, a detailed understanding of the cellular and neural pathways used by the PVH to regulate these physiologic functions has been complicated by the heterogeneity of this nucleus and the inability to investigate specific PVH cell populations independently. To tackle these issues, we combined Credependent viral vectors with PVH cell-specific Cre drivers to probe the function of discrete PVH neuron subsets and explore their connectivity with brain regions known to be involved in energy homeostasis.
The hypothalamic transcription factor Sim1 marks PVH neurons involved in feeding regulation. Sim1-restricted melanocortin-4 receptor (Mc4R) expression in an otherwise Mc4R-null background corrects the associated hyperphagia of Mc4R-null mice and targeted ablation of Sim1 neurons in the CNS results in hyperphagia and altered energy expenditure (Balthasar et al., 2005; Xi et al., 2012) . Sim1 neurons lie in other brain areas, but most if not all PVH neurons express Sim1 (Michaud et al., 1998). We now show that acute activation of Sim1 PVH neurons suppresses feeding and increases energy expenditure and activity, highlighting the ability of PVH neurons to PVH neurons increases subcutaneous intrascapular temperature. Sim1-Creϩ3Dq, OXT-iCreϩ3Dq, and WTϩ3Dq mice received temperature transponders in the subcutaneous intrascapular tissue directly above BAT. T IS was measured before and after vehicle or CNO administration. A, B, T IS is shown relative to baseline T IS before and after injection of vehicle or CNO (A, dashed and solid lines, respectively) and also is represented as the peak area under the curve (B). Average values Ϯ SEM are shown. *p Ͻ 0.05, **p Ͻ 0.01, ***p Ͻ 0.001 compared with vehicle values (WT, n ϭ 5; Sim1-Cre, n ϭ 3; OXT-iCre, n ϭ 4). Significance was determined using repeated-measures two-way ANOVA with Sidak multiple-comparisons post hoc test. regulate both energy balance parameters and validating our experimental system. To clarify the neurochemical identity and neural circuitry of the PVH neurons mediating these effects, we identified and used Nos1 expression to mark a specific Sim1 PVH subset. Our tracing studies revealed dense Nos1 PVH projections to hindbrain and spinal cord structures involved in energy balance regulation. Using a pharmacogenetic approach, we showed that activation of Nos1 PVH neurons suppressed food intake at the onset of feeding to an extent that is comparable to that observed upon activation of the entire Sim1 PVH field. These experiments therefore establish Nos1 PVH neurons as an important Sim1 PVH subset in feeding regulation. OXT PVH neurons are a subset of Nos1 PVH neurons and pharmacologic evidence has demonstrated the ability of hindbrain OXT action to suppress feeding, suggesting a role for OXT PVH neurons in anorectic signaling by the PVH (Blevins et al., 2004; Tolson et al., 2010) . In contrast, however, genetic inactivation of OXT or its receptors minimally impacts feeding, and ablation of OXT neurons in adult mice neither alters feeding nor the anorexic response to a melanocortin agonist (Takayanagi et al., 2008; Camerino, 2009; Wu et al., 2012) . To determine the contribution of OXT PVH neurons to Nos1 PVH -regulated feeding, we subjected OXT PVH neurons to Cre-dependent synaptic tracing and pharmacogenetic analysis. DREADD-mediated activation of OXT PVH neurons failed to suppress feeding under normal conditions. Therefore, while Nos1
PVH neurons mediate a powerful anorectic signal, the OXT-expressing subset of Nos1 PVH neurons cannot account for this effect, thus revealing a requisite role for non-OXT Nos1 PVH neurons in food intake control. The role of the PVH in energy expenditure regulation has received less attention than its role in food intake control. Sim1 haploinsufficiency or manipulation of Mc4R expression in Sim1 neurons alters feeding, but minimally affects energy expenditure (Michaud et al., 2001; Balthasar et al., 2005) . Selective ablation of Sim1 neurons in the CNS, however, lowers oxygen consumption, suggesting a role for Sim1 neurons in the regulation of both food intake and energy expenditure (Xi et al., 2012) . Indeed, recent data reveal that glutamatergic signaling in Sim1 neurons contributes to energy expenditure regulation (Xu et al., 2013) neurons provides a potential neuroanatomical mechanism by which sympathetic output may be increased to promote energy expenditure following activation of these PVH neurons. Indeed, activation of Sim1 PVH neurons increases intrascapular temperature overlying BAT. As thermogenesis requires BAT UCP1 (Cannon and Nedergaard, 2004) , and there is no change in UCP1 protein expression following Sim1 PVH stimulation, this effect is likely dependent on a change in UCP1 activity.
The increase in oxygen consumption upon Sim1 PVH activation is more robust than that seen with activation of either Nos1 PVH or OXT PVH neurons alone. Interestingly, the extent of ChAT IML activation is relatively similar, suggesting that additional CNS pathways are engaged to regulate energy expenditure acutely. Only an estimated 25% of hindbrain and spinal cordprojecting PVH neurons have been neurochemically defined (Sawchenko and Swanson, 1982) . Therefore, other, unidentified PVH neurons likely play important roles in modulating energy expenditure. Additional studies directed at identifying and manipulating chemically defined populations of PVH neurons will be critical in understanding the cellular and neuroanatomical pathways used by the PVH to modulate energy expenditure and achieve energy homeostasis.
The neurotransmitters by which Nos1 PVH and OXT PVH neurons regulate feeding and energy expenditure remain undefined. It is likely that both neuropeptides and fast-acting neurotransmitters such as glutamate, the predominant PVH neurotransmitter, contribute to PVH-mediated energy balance. Indeed, Sim1 glutamate signaling is important for overall control of energy balance (Xu et al., 2013) . Our DREADD activation studies suggest the possibility that PVH neurons regulate adjacent cells. Given the presence of local, intra-PVH glutamatergic connections, it is conceivable that PVH neuronal subsets can recruit certain neighboring cell types to affect functional outputs (Ziegler and Herman, 2000) .
Overall, our dissection of PVH neuron subpopulations reveals that specific subsets of PVH neurons play distinct roles in energy balance regulation. Specifically, we reveal a role for Nos1
PVH neurons in the control of feeding, and that this function requires the participation of non-OXT Nos1 PVH neurons. Moreover, both 
Nos1
PVH and the OXT PVH neurons project to sympathetic output areas of the thoracic spinal cord and are capable of increasing energy expenditure (although to a lesser extent than Sim1 PVH neurons, suggesting roles for non-Nos1 Sim1 PVH cells). The identification and analysis of other PVH subpopulations will be crucial to determining the molecular mechanisms by which the PVH regulates energy homeostasis.
